Clinical evaluation of medicinal products intended for treatment of hepatitis B

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/EWP/6172/2003
Published23/02/2006
Effective from01/09/2006
KeywordsHepatitis B, diagnostic criteria, non-inferiority trials, superiority trials, endpoints, comparator, special populations, safety evaluation
DescriptionThis document provides guidance on the clinical evaluation of new medicinal products in the treatment of chronic hepatitis B.



Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more